Advances in nondietary management of children with atopic dermatitis.
This paper discusses recent advances in therapy of atopic dermatitis (AD), excluding those that include dietary management. Some of these therapies are anecdotal, experimental, or somewhat controversial. It is important to emphasize that physicians should not try what is new without first having given standard therapy a long and reasonable chance to succeed. This is important because AD does not last forever, and in many patients, mild disease heals spontaneously.
Rasmussen
J E
JE
Department of Dermatology, University of Michigan, Ann Arbor 48109-0314.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D004391:Dust; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D005228:Fatty Acids, Essential / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008041:Linoleic Acids; D008925:Mites; D031665:Oenothera biennis; D010938:Plant Oils; D014467:Ultraviolet Therapy; D017965:gamma-Linolenic Acid
D000305:Adrenal Cortex Hormones; D004391:Dust; D005228:Fatty Acids, Essential; D007166:Immunosuppressive Agents; D008041:Linoleic Acids; D010938:Plant Oils; C028498:evening primrose oil; D017965:gamma-Linolenic Acid; D015118:Eicosapentaenoic Acid; D015105:3',5'-Cyclic-AMP Phosphodiesterases